Key Players in the South Korea Anaphylaxis Market | Top Companies & Insights 2026

South Korea Anaphylaxis Market Overview

According to 6Wresearch, the South Korea anaphylaxis market is growing further, due to the rising prevalence of severe allergic disorders, specifically food allergies and insect sting hypersensitivity, combined with increasing social awareness about emergency treatments. Epinephrine is known as the first-line therapy, that balances physiological responses by constricting blood vessels and opening the airways in the lungs. The growth of the market is being driven by the increased use of auto-injector alternatives and hospital-based emergency care. The healthcare infrastructure is becoming more specialized with more and more allergy clinics and emergency departments leading to an expansion in the pharmaceutical supply chain for life saving anti-allergy drugs.

Competitive Landscape

The competitive landscape of South Korea Anaphylaxis Industry involves local distributors and global pharmaceutical giants, that provide a range of dosage forms, including epinephrine auto-injectors, pre-filled syringes, and growing needle-free nasal sprays. To build patient adherence, the industry leaders are creating cost effective treatments and novel delivery systems.

Below is a list of leading players operating in the South Korea Anaphylaxis Market:

1. Viatris Korea (Mylan)

Viatris is a global leader in the anaphylaxis segment, providing the widely recognized EpiPen, which remains a cornerstone in emergency allergy management.

2. Bayer Korea

Bayer is a major player in the immunology space, focusing on long-term allergy management and clinical solutions for severe allergic reactions.

3. Handok Inc.

Handok is a research-driven company specializing in total healthcare and is a key distributor of advanced emergency treatments through strategic global partnerships.

4. Yuhan Corporation

Yuhan provides high-quality pharmaceutical solutions, ensuring that life-saving medications and supportive allergy treatments are accessible and affordable.

5. GC Biopharma (Green Cross)

GC Biopharma maintains a strong presence in the plasma-derived protein and immunology segment, supporting the management of systemic allergic reactions.

6. Daewoong Pharmaceutical

Daewoong is a leading domestic manufacturer providing essential medications and contributing to the local supply of antihistamines and supportive emergency treatments.

7. Huons Co., Ltd.

Huons leverages its extensive local production capabilities to provide injectable medications and specialized delivery systems used in the care of allergic emergencies.

8. Boryung Corp.

Boryung is a leader in respiratory and cardiovascular health, offering a portfolio of medications that manage the underlying conditions leading to severe allergic episodes.

9. Jeil Pharmaceutical

Jeil Pharmaceutical maintains a strong presence in the emergency medicine segment, producing essential injectable medications used in clinical and hospital-based allergy care.

10. Samjin Pharm

Samjin Pharm provides a diverse range of specialty products that support hospital-based care and the management of acute systemic reactions.